The company analyzes cancer cells to identify new drug targets that exploit vulnerabilities and overcome chemotherapy resistance. Their goal is to develop therapeutics that significantly improve treatment options and enhance the lives of patients. Founded in 2012 and based in Belfast, UK, CV6 Therapeutics is an early-stage drug development company dedicated to improving patient outcomes through novel combination therapies. For investment inquiries, contact [email protected].